Provider
Combination Non-Steroidal Anti-Inflammatory Drugs (NSAID) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jul 01, 2024
Search Results
Displaying 2051 - 2060 of 3661 results
Provider
QP5-22 New Access Point for Prior Authorization Look Up Tool and Blue Cross Website Updates
Program effective Date: Jan 12, 2022
Provider
QP6-22 New Telehealth Place of Service Code 10
Program effective Date: Jan 12, 2022
Provider
P1-22 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Program effective Date: Jan 03, 2022
Provider
P2-22 Removal of Prior Authorization Requirement - Effective January 31, 2022
Program effective Date: Jan 03, 2022
Provider
P3-22 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
Program effective Date: Jan 03, 2022
Provider
QP3-22 Commercial Pharmacy Benefit Exclusion for Loreev XR and Sertraline Capsules
Program effective Date: Jan 12, 2022
Provider
QP4-22 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective March 1, 2022
Program effective Date: Jan 12, 2022
Provider
QP1-22 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective March 15, 2022
Program effective Date: Jan 12, 2022
Provider
QP2-22 MHCP Pharmacy Benefit Exclusion for Nexviazyme™
Program effective Date: Jan 12, 2022